Healthscope said on current information, the group is on track to deliver the forecasts included in its prospectus, notably fiscal 2015 operating EBITDA of $387. 3m and operating EBIT of $284. 7m.
Healthscope, which relisted on the ASX just over a month ago in a $3. 6 billion float, delivered a full-year loss of $19. 3m, a far improved performance on the $145. 1m contained in the statutory forecasts in Healthscope’s prospectus. Revenue was $2. 3bn, a lift of 5.
Healthscope, the biggest sharemarket listing in four years, remains on track to meet the fiscal 2015 earnings guidance laid out in its prospectus.
Alan has been a trusted source of investment advice to Australians for many years, and in 2005 he founded Eureka Report - Australia’s #1 online investment report.
Read more here: Business Spectator